Ferrovial ups bid for Broadspectrum shares to $1.50

But Broadspectrum Ltd (ASX:BRS) board rejects bid

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Spanish construction and contracting giant, Ferrovial, has lifted its bid for Broadspectrum Ltd (ASX: BRS) ex-Transfield Services to $1.50 per share.

The company says the revised bid is its final offer, but Broadspectrum has again told shareholders to reject the bid, as it is below the independent expert's valuation.

Chairman Diane Smith-Gander said in a statement, "While the increase in the Offer is positive for shareholders, the Revised Offer continues to undervalue Broadspectrum's shares."

Accounting firm Ernst & Young valued the shares at between $1.71 and $1.98 in early January 2016.

In December 2014, Ferrovial had been prepared to offer $2.00 per share according to the company, and Broadspectrum says it is in a much better position now.

The company also announced today that it expects to report underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of between $280 and $300 million for the 2016 financial year (FY16).

Broadspectrum says it is positive about FY17 as well, forecasting underlying EBITDA "to be in excess of $300 million".

Net debt is also expected to reduce further to between $370 and $390 million by the end of June 2016.

Investors don't appear to think the takeover will proceed now that Ferrovial has declared the offer Final and Broadspectrum's board has rejected it. Ferrovial now can't make another bid, even if it was higher, and Broadspectrum's share price is up 4% to $1.30 – well below the $1.50 offer price per share.

Now it all depends on how many institutional shareholders take up the offer, with Ferrovial needing 50.1% of all shares to acquire the company.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »